High dose Tigecycline independently associated with six fold increase in
clinical cure.
Well tolerated with no cases of discontinuation or dose reduction
because of adverse events.
High dose used to treat MDR Klebsiella & Acinetobacter Urosepsis
resistant to other antibiotics.
Active against multiple MDR & ESBL Pathogens.
Active against carbapenem Resistant Acinetobacter baumannii strains.
Reconstitute the content of vial with 0.9%w/v of sodium chloride
injection IP or 5% dextrose injection or as prescribed by physician.
